BriaCell Therapeutics (BCTX) Insider Trading & Ownership

$2.19
-0.13 (-5.60%)
(As of 04/24/2024 ET)

BriaCell Therapeutics (NASDAQ:BCTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.77%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$245,940.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get BCTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling BriaCell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BCTX Insider Buying and Selling by Quarter

BriaCell Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/28/2022Jamieson BondarenkoChairmanBuy28,000$4.58$128,240.00  
12/20/2022Jamieson BondarenkoDirectorBuy22,000$5.35$117,700.00  
(Data available from 1/1/2013 forward)

BCTX Insider Trading Activity - Frequently Asked Questions

Who is on BriaCell Therapeutics's Insider Roster?

The list of insiders at BriaCell Therapeutics includes Jamieson Bondarenko. Learn more on insiders at BCTX.

What percentage of BriaCell Therapeutics stock is owned by insiders?

21.77% of BriaCell Therapeutics stock is owned by insiders. Learn more on BCTX's insider holdings.

Which BriaCell Therapeutics insiders have been buying company stock?

The following insider purchased BCTX shares in the last 24 months: Jamieson Bondarenko ($245,940.00).

How much insider buying is happening at BriaCell Therapeutics?

Insiders have purchased a total of 50,000 BCTX shares in the last 24 months for a total of $245,940.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:BCTX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners